ACIU - AC Immune's Alzheimer's Setback And Other News: The Good Bad And Ugly Of Biopharma
- AC Immune suffers setback on Alzheimer’s front.
- Galera Therapeutics provides positive update of GC4419 in pancreatic cancer.
- Forma Therapeutics reports positive topline data from Phase 2 Olutasidenib trial.
For further details see:
AC Immune's Alzheimer's Setback, And Other News: The Good, Bad And Ugly Of Biopharma